Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif

Virology

Volumn 339, Issue 2, 2005, Pages 281-288

  Doehle, Brian P ^a   Schäfer, Alexandra ^a   Cullen, Bryan R ^a  

^a NONE

Author keywords

APOBEC3B; HIV; Intrinsic immunity; Retrovirus

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN B MRNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; GAG PROTEIN; ISOPROTEIN; NUCLEOCAPSID PROTEIN; POLYPEPTIDE; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; FUNCTIONAL PROTEOMICS; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOID CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; VIRION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

APOLIPOPROTEINS B; CELLS, CULTURED; CYTIDINE DEAMINASE; GENE PRODUCTS, VIF; HIV INFECTIONS; HIV-1; HUMANS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 23844483541     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.06.005     Document Type: Article

References (35)

1. M.A. Accola, B. Strack, and H.G. Göttlinger Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain J. Virol. 74 2000 5395 5402
2. T.M. Alce, and W. Popik APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein J. Biol. Chem. 279 2004 34083 34086
3. P.D. Bieniasz Intrinsic immunity: a front-line defense against viral attack Nat. Immunol. 11 2004 1109 1115
4. K.N. Bishop, R.K. Holmes, A.M. Sheehy, N.O. Davidson, S.-J. Cho, and M.H. Malim Cytidine deamination of retroviral DNA by diverse APOBEC proteins Curr. Biol. 14 2004 1392 1396
5. H.P. Bogerd, B.P. Doehle, H.L. Wiegand, and B.R. Cullen A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor Proc. Natl. Acad. Sci. U.S.A. 101 2004 3770 3774
6. S. Cen, F. Guo, M. Niu, J. Saadatmand, J. Deflassieux, and L. Kleiman The interaction between HIV-1 Gag and APOBEC3G J. Biol. Chem. 279 2004 33177 33184
7. B. Chesebro, K. Wehrly, J. Nishio, and S. Perryman Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism J. Virol. 66 1992 6547 6554
8. S.G. Conticello, R.S. Harris, and M.S. Neuberger The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G Curr. Biol. 13 2003 2009 2013
9. S. Cowan, T. Hatziioannou, T. Cunningham, M.A. Muesing, H.G. Göttlinger, and P.D. Bieniasz Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism Proc. Natl. Acad. Sci. U.S.A. 99 2002 11914 11919
10. B.P. Doehle, A. Schäfer, H.L. Wiegand, H.P. Bogerd, and B.R. Cullen Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion J. Virol. 79 2005 8201 8207
11. J.A. Dutko, A. Schäfer, A.E. Kenny, B.R. Cullen, and M.J. Curcio Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases Curr. Biol. 15 2005 661 666
12. C. Esnault, O. Heidmann, F. Delebecque, M. Dewannleux, D. Ribet, A.J. Hance, T. Heidmann, and O. Schwartz APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses Nature 433 2005 430 433
13. J. Goncalves, Y. Korin, J. Zack, and D. Gabuzda Role of Vif in human immunodeficiency virus type 1 reverse transcription J. Virol. 70 1996 8701 8709
14. A. Jarmuz, A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam An anthropoid-specific locus of orphan C to U RNA-editing enzymes on Chromosome 22 Genomics 79 2002 285 296
15. S. Kao, M.A. Khan, E. Miyagi, R. Plishka, A. Buckler-White, and K. Strebel The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity J. Virol. 77 2003 11398 11407
16. M. Kobayashi, A. Takaori-Kondo, K. Shindo, A. Abudu, K. Fukunaga, and T. Uchiyama APOBEC3G targets specific virus species J. Virol. 78 2004 8238 8244
17. M.A. Langlois, R.C. Beale, S.G. Conticello, and M.S. Neuberger Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities Nucleic Acids Res. 33 2005 1913 1923
18. M.T. Liddament, W.L. Brown, A.J. Schumacher, and R.S. Harris APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo Curr. Biol. 14 2004 1385 1391
19. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
20. B. Mangeat, P. Turelli, S. Liao, and D. Trono A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action J. Biol. Chem. 279 2004 14481 14483
21. R. Mariani, D. Chen, B. Schröfelbauer, F. Navarro, R. König, B. Bollman, C. Münk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 2003 21 31
22. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9 2003 1398 1403
23. A. Mehle, B. Strack, P. Ancuta, C. Zhang, M.N. McPike, and D. Gabuzda Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway J. Biol. Chem. 279 2004 7792 7798
24. A. Schäfer, H.P. Bogerd, and B.R. Cullen Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor Virology 328 2004 163 168
25. S.L. Schrier, and E. Angelucci New strategies in the treatment of the thalassemias Annu. Rev. Med. 56 2005 157 171
26. B. Schröfelbauer, D. Chen, and N.R. Landau A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) Proc. Natl. Acad. Sci. U.S.A. 101 2004 3927 3932
27. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 2002 646 650
28. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 2003 1404 1407
29. J.H.M. Simon, D.L. Miller, R.A.M. Fouchier, M.A. Soares, K.W.C. Peden, and M.H. Malim The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission EMBO J. 17 1998 1259 1267
30. K. Stopak, C. de Noronha, W. Yonemoto, and W.C. Greene HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol. Cell 12 2003 591 601
31. H.L. Wiegand, B.P. Doehle, H.P. Bogerd, and B.R. Cullen The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission EMBO J. 23 2004 2451 2458
32. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.-F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 2003 1056 1060
33. Q. Yu, D. Chen, R. König, R. Mariani, D. Unutmaz, and N.R. Landau APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication J. Biol. Chem. 279 2004 53379 53386
34. V. Zennou, D. Perez-Caballero, H. Göttlinger, and P.D. Bieniasz APOBEC3G incorporation into human immunodeficiency virus type 1 particles J. Virol. 78 2004 12058 12061
35. Y.-H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B.M. Peterlin Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J. Virol. 78 2004 6073 6076